The MedicX Fund Limited Notice of dividend (9990N)
November 01 2016 - 7:15AM
UK Regulatory
TIDMMXF
RNS Number : 9990N
The MedicX Fund Limited
01 November 2016
Press Release
For immediate release
1 November 2016
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Notice of dividend
The Directors have approved a quarterly dividend of 1.4875p per
Ordinary Share in respect of the period 1 July 2016 to 30 September
2016. This will bring the total dividends declared in respect of
the financial year ended 30 September 2016 to 5.95p per Ordinary
Share, an increase of 0.85% over the dividends totalling 5.9p
declared for the previous year ended 30 September 2015. The
dividend will be paid on 31 December 2016 to ordinary shareholders
on the register as at 18 November 2016 (the "Record Date"). The
corresponding ex-dividend date will be 17 November 2016.
The Company is offering qualifying shareholders the opportunity
to take new ordinary shares in the Company, credited as fully paid,
in lieu of the cash dividend to be paid on 31 December 2016, by
participating in the Scrip Dividend Scheme (the "Scheme")
previously put in place by the Company on 5 May 2010.
The option to participate will be available to shareholders
until 7 December 2016 (the "election date"). Further information on
the Scheme, together with a copy of the Scheme Document (which
contains the terms and conditions of the Scheme) and relevant
mandate form document, is available for inspection at the National
Storage Mechanism (http://www.morningstar.co.uk/uk/nsm), or through
the Scrip Dividend portal on the Company's website
(http://www.medicxfund.com/scrip).
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Victoria Hayns
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or
together with its subsidiaries, the "Group") is the specialist
primary care infrastructure investor in modern, purpose-built
primary healthcare properties in the United Kingdom and Ireland,
listed on the London Stock Exchange, with a portfolio comprising
153 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1 billion of healthcare investments across a number of
platforms, with a focus on four core areas: GP surgeries, care
homes, retirement housing and private hospitals. Octopus Healthcare
is part of the Octopus group, a fast-growing UK fund management
business with leading positions in several specialist sectors
including healthcare property, energy, property finance and smaller
company investing. Octopus manages GBP6 billion of funds for more
than 50,000 retail and institutional investors.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DIVGMMGMMMLGVZM
(END) Dow Jones Newswires
November 01, 2016 07:15 ET (11:15 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024